SZ003
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for SZ003, covering 2025-01-29 to 2025-01-29. Get the full timeline:
Most recent: Clinical Trial Update: Single-arm, Open-label Clinical Study of SZ003 in the Treatment of Advanced Hepatocellular Carcinoma [NA]